[A Case of Unresectable Advanced Gastric Cancer Treated by Seven Courses of Chemotherapy with Docetaxel, Cisplatin, and S-1Followed by Conversion Surgery Achieved Five Year Relapse Free Survival].

MLA

Nakajima, Tetsushi, et al. “[A Case of Unresectable Advanced Gastric Cancer Treated by Seven Courses of Chemotherapy with Docetaxel, Cisplatin, and S-1Followed by Conversion Surgery Achieved Five Year Relapse Free Survival].” Gan to Kagaku Ryoho. Cancer & Chemotherapy, vol. 45, no. 4, Apr. 2018, pp. 755–57. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=cmedm&AN=29650858&authtype=sso&custid=ns315887.

APA

Nakajima, T., Cho, H., Okubo, Y., Kano, K., Maezawa, Y., Ikeda, K., Yamada, T., Ogata, T., & Yoshikawa, T. (2018). [A Case of Unresectable Advanced Gastric Cancer Treated by Seven Courses of Chemotherapy with Docetaxel, Cisplatin, and S-1Followed by Conversion Surgery Achieved Five Year Relapse Free Survival]. Gan to Kagaku Ryoho. Cancer & Chemotherapy, 45(4), 755–757.

Chicago

Nakajima, Tetsushi, Haruhiko Cho, Yoichiro Okubo, Kazuki Kano, Yukio Maezawa, Kousuke Ikeda, Takanobu Yamada, Takashi Ogata, and Takaki Yoshikawa. 2018. “[A Case of Unresectable Advanced Gastric Cancer Treated by Seven Courses of Chemotherapy with Docetaxel, Cisplatin, and S-1Followed by Conversion Surgery Achieved Five Year Relapse Free Survival].” Gan to Kagaku Ryoho. Cancer & Chemotherapy 45 (4): 755–57. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=cmedm&AN=29650858&authtype=sso&custid=ns315887.